| Freehill Mining Limited (FHS) ORDINARY FULLY PAID |
Materials |
$11 |
Third Aggregates Supply and Processing Site Secured
|
11 Jun 2025 8:53AM |
$0.008 |
$0.003 |
fallen by
62.50%
|
|
FHS - Price-sensitive ASX Announcement
Full Release
Key Points
- Freehill Mining Limited has secured a third aggregates supply and processing site in La Negra, Antofagasta, Chile.
- The site acquisition is aligned with the company’s strategy to significantly expand its aggregates business.
- Strong demand for aggregates is anticipated in the region, particularly from infrastructure and mining projects.
- The new site provides logistical advantages, including proximity to key customers and transport networks.
- This expansion enhances Freehill’s ability to meet customer needs with increased volume and supply continuity.
- The company expects the new site to contribute positively to revenue growth and long-term business sustainability.
- Freehill remains committed to further expanding its footprint in the aggregates sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$318 |
Update - Notification of buy-back - PIA
|
11 Jun 2025 8:52AM |
$1.190 |
$1.235 |
risen by
3.78%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,368 |
Update - Notification of buy-back - MFG
|
11 Jun 2025 8:52AM |
$8.670 |
$8.140 |
fallen by
6.11%
|
|
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,091 |
Olympus launches new SeleCT Screening campaign
|
11 Jun 2025 8:51AM |
$0.300 |
$3.670 |
risen by
1,123.33%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- Olympus launches the SeleCT Screening campaign focused on early lung cancer detection.
- The campaign emphasizes the crucial role of advanced imaging in early diagnosis.
- 4DMedical Limited's XV Technology® is highlighted as an innovative lung imaging solution.
- The initiative seeks to raise awareness and improve lung cancer screening participation.
- Collaboration between Olympus and 4DMedical aims to improve patient outcomes by enabling earlier and more accurate detection.
- SeleCT Screening campaign supports healthcare professionals with access to new diagnostic tools.
- The announcement reinforces the importance of technology-driven solutions in the fight against lung cancer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,526 |
CEO transition and appointment of interim CFO
|
11 Jun 2025 8:50AM |
$5.270 |
$5.600 |
risen by
6.26%
|
|
HLI - Price-sensitive ASX Announcement
Full Release
Key Points
- Pauline Blight-Johnston, CEO of Helia Group Limited, will step down effective 30 November 2024.
- The Helia Board will begin the search for a new CEO.
- Pauline Blight-Johnston will remain until the end of November to assist with transition.
- Peter McKenna is appointed as interim CFO following the resignation of Mark Barry.
- Mark Barry will leave his CFO role effective 30 June 2024.
- Leadership changes aim to ensure stability and continuity for Helia.
- The company has thanked both departing executives for their service.
- Helia expresses confidence in its ability to manage the executive transitions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Delorean Corporation Limited (DEL) ORDINARY FULLY PAID |
Utilities |
$20 |
Investor Update Presentation
|
11 Jun 2025 8:49AM |
$0.170 |
$0.092 |
fallen by
45.88%
|
|
DEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Delorean Corporation specializes in renewable bioenergy, focusing on anaerobic digestion technology.
- The company develops, constructs, owns, and operates bioenergy infrastructure that converts organic waste into renewable electricity and gas.
- Delorean’s business model includes revenue from engineering, procurement, construction, energy sales, and waste management.
- Several projects are in various stages of development and construction across Australia and New Zealand.
- The company is diversifying its revenue base by moving towards project ownership and long-term energy sales.
- Financial performance is detailed, including revenue, EBITDA, and project pipeline updates.
- Delorean is positioning itself as a leader in the circular economy and renewable energy transition.
- Strategic growth opportunities include expanding project pipeline, geographic reach, and leveraging technology partnerships.
- The presentation outlines risks, opportunities, and market drivers influencing Delorean’s operations and growth.
- Commitment to environmental sustainability and reducing carbon emissions is a core aspect of Delorean’s identity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,096 |
Update - Notification of buy-back - AOV
|
11 Jun 2025 8:47AM |
$7.840 |
$8.185 |
risen by
4.40%
|
|
| G50 Corp Limited (G50) ORDINARY FULLY PAID |
Materials |
$174 |
Positive Gallium Mineralogy Outcome
|
11 Jun 2025 8:42AM |
$0.190 |
$0.850 |
risen by
347.37%
|
|
G50 - Price-sensitive ASX Announcement
Full Release
Key Points
- G50 Corp Limited reported positive gallium mineralogy results from its Mount Isa Project.
- Gallium is present in significant quantities within the project’s mineral matrix.
- Mineralogical analysis supports the potential for gallium extraction as a by-product.
- The project is aligned with the company's strategy to develop critical minerals resources.
- Encouraging mineralogy outcomes are expected to contribute to future project development plans.
- The announcement underscores the importance of gallium as a critical mineral in modern technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$28 |
Notice under section 708A(5) of the Corporations Act 2001
|
11 Jun 2025 8:42AM |
$0.048 |
$0.073 |
risen by
52.08%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,727 |
Update - Notification of buy-back - ORA
|
11 Jun 2025 8:41AM |
$1.880 |
$2.210 |
risen by
17.55%
|
|
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$45 |
Update - Notification of buy-back - IBC
|
11 Jun 2025 8:38AM |
$0.440 |
$0.445 |
risen by
1.14%
|
|
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,937 |
IperionX Secures First U.S. Army Order Under US$99M Contract
|
11 Jun 2025 8:37AM |
$4.170 |
$5.730 |
risen by
37.41%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX Limited (IPX) secures first order from U.S. Army under a U.S. Department of Defense IDIQ contract.
- The contract has a ceiling value of US$99 million over five years.
- Order is for the supply of high-quality titanium metal powder produced using IperionX’s sustainable and proprietary technologies.
- Supports U.S. government policy for a secure domestic supply chain for critical minerals and defense applications.
- IperionX’s technologies enable the production of low-cost, fully recycled titanium from scrap or minerals.
- The initial delivery order demonstrates the Army’s commitment to strengthening domestic titanium capabilities.
- IDIQ contract allows for multiple future orders up to the maximum contract value.
- Agreement enhances IperionX’s position as a strategic partner for U.S. defense supply chains.
- Highlights the critical role of titanium in defense and advanced manufacturing sectors.
- Represents a major commercial milestone for IperionX’s business growth and U.S. industrial base support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| iShares MSCI Japan ETF (IJP) |
Financials |
$1,284 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$113.320 |
$129.085 |
risen by
13.91%
|
|
| iShares MSCI Emerging Markets Ex China ETF (EMXC) |
Financials |
$452 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$28.120 |
$35.800 |
risen by
27.31%
|
|
| iShares Global Healthcare ETF (IXJ) |
Financials |
$1,419 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$132.150 |
$141.245 |
risen by
6.88%
|
|
| iShares Edge MSCI World Multifactor ETF (WDMF) |
Financials |
$156 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$49.080 |
$50.840 |
risen by
3.59%
|
|
| iShares Global Consumer Staples ETF (IXI) |
Financials |
$175 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$101.380 |
$103.010 |
risen by
1.61%
|
|
| iShares Europe ETF (IEU) |
Financials |
$914 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$97.880 |
$101.450 |
risen by
3.65%
|
|
| iShares S&P 500 ETF (IVV) |
Financials |
$12,478 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$61.570 |
$64.430 |
risen by
4.65%
|
|
| iShares S&P Mid-Cap ETF (IJH) |
Financials |
$476 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$47.160 |
$50.335 |
risen by
6.73%
|
|
| Ishares Global 100 AUD Hedged ETF (IHOO) |
Financials |
$642 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$189.130 |
$227.000 |
risen by
20.02%
|
|
| iShares MSCI EAFE ETF (IVE) |
Financials |
$666 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$137.180 |
$144.960 |
risen by
5.67%
|
|
| iShares S&P Small-Cap ETF (IJR) |
Financials |
$790 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$167.950 |
$185.740 |
risen by
10.59%
|
|
| iShares MSCI Emerging Markets ETF (IEM) |
Financials |
$1,555 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$72.940 |
$87.310 |
risen by
19.70%
|
|
| iShares Edge MSCI World Minimum Volatility ETF (WVOL) |
Financials |
$79 |
PRODUCT DISCLOSURE STATEMENT
|
11 Jun 2025 8:37AM |
$43.900 |
$44.910 |
risen by
2.30%
|
|